Marketing-authorisation holder
Hikma Canada Limited
105 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
105 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 105
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION USP9 mg / ml · Solution | Sodium chloride | Canada | Marketed | 2008 |
| ACETYLCYSTEINE SOLUTION USP200 mg / ml · Solution | Acetylcysteine | Canada | Marketed | 2018 |
| ATROPINE INJECTION BP0.4 mg / ml · Solution | Atropine | Canada | Marketed | 2015 |
| ATROPINE INJECTION BP0.6 mg / ml · Solution | Atropine | Canada | Marketed | 2016 |
| AZACITIDINE FOR INJECTION100 mg / vial · Powder For Suspension | Azacitidine | Canada | Marketed | 2022 |
| BACLOFEN INJECTION2 mg / ml · Solution | Baclofen | Canada | Marketed | 2017 |
| BACLOFEN INJECTION0.05 mg / ml · Solution | Baclofen | Canada | Not marketed | 2017 |
| BACLOFEN INJECTION0.5 mg / ml · Solution | Baclofen | Canada | Not marketed | 2017 |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION25 mg / vial · Powder For Solution | Bendamustine | Canada | Authorised | |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION100 mg / vial · Powder For Solution | Bendamustine | Canada | Authorised | |
| BORTEZOMIB FOR INJECTION3.5 mg / vial · Powder For Solution | Bortezomib | Canada | Authorised | |
| BUPIVACAINE HYDROCHLORIDE INJECTION USP2.5 mg / ml · Solution | Bupivacaine | Canada | Authorised | |
| BUPIVACAINE HYDROCHLORIDE INJECTION USP5 mg / ml · Solution | Bupivacaine | Canada | Authorised | |
| CEFAZOLIN FOR INJECTION500 mg / vial · Powder For Solution | Cefazolin | Canada | Marketed | 2015 |
| CEFAZOLIN FOR INJECTION10 g / vial · Powder For Solution | Cefazolin | Canada | Marketed | 2015 |
| CEFAZOLIN FOR INJECTION1 g / vial · Powder For Solution | Cefazolin | Canada | Marketed | 2015 |
| CEFEPIME FOR INJECTION USP1 g / vial · Powder For Solution | Cefepime | Canada | Authorised | |
| CEFEPIME FOR INJECTION USP2 g / vial · Powder For Solution | Cefepime | Canada | Marketed | 2021 |
| CEFUROXIME FOR INJECTION, USP7.5 g / vial · Powder For Solution | Cefuroxime | Canada | Not marketed | 2015 |
| CEFUROXIME FOR INJECTION, USP1.5 g / vial · Powder For Solution | Cefuroxime | Canada | Not marketed | 2015 |
| CEFUROXIME FOR INJECTION, USP750 mg / vial · Powder For Solution | Cefuroxime | Canada | Not marketed | 2015 |
| CISATRACURIUM BESYLATE INJECTION, USP MULTI-DOSE2 mg / ml · Solution | Cisatracurium | Canada | Authorised | |
| CISPLATIN INJECTION BP1 mg / ml · Solution | Cisplatin | Canada | Marketed | 2024 |
| CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP1 % / w/v · Solution | Clindamycin | Canada | Not marketed | 2019 |
| CYANOCOBALAMIN INJECTION USP1000 mcg / ml · Solution | Vitamin b12 | Canada | Marketed | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 105 | 95 | 10 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.